Serum S100A8 / A9 Correlates to Surgery‐Free Interval in Idiopathic Subglottic Stenosis
The Laryngoscope · 2025
DOI: 10.1002/lary.31934 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2025. Verfasst von Laura M Mafla und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A. Hauptthemen laut MEDLINE: Laryngostenosis, Calgranulin B, Calgranulin A. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCD NIH HHS, NHLBI NIH HHS, National Institute on Deafness and Other Communication Disorders.
Abstract (Originalsprache)
Objective
Idiopathic subglottic stenosis (iSGS) is a progressive fibrotic condition of the subglottis that presents in women of northern European descent. Endoscopic dilation is a common surgical approach to management of iSGS. The surgery‐free interval, or the time between endoscopic dilation procedures is considered an indicator of disease severity. Variations in surgery‐free intervals among iSGS patients underscore the necessity for prognostic biomarkers. The objective of this study was to explore serum levels of the damage‐associated molecular pattern S100A8/A9 as a prognostic biomarker in iSGS.
Methods
Serum from 20 iSGS patients and eight healthy controls was collected and S100A8/A9 levels were quantified using an ELISA. Patient data, including demographics and surgery‐free intervals, were obtained from medical records. Serum S100A8/A9 levels were compared to surgery‐free intervals. S100A8/A9 was also assessed using gene expression and immunofluorescence in iSGS specimens.
Results
S100A8/A9 was significantly elevated ( p = 0.0413) in the serum of iSGS patients compared to controls (312.75 vs. 181.49 ng/mL). Linear regression analysis revealed a correlation ( p = 0.009) between S100A8/A9 levels and endoscopic surgery‐free interval. S100A8/A9 was significantly elevated ( p = 0.0011) in patients with surgery‐free intervals less than 1 year (455.2 ± 60.45 ng/mL; n = 8) compared to patients with intervals over 1 year (292.5.93 ± 162.4; n = 6).
Conclusion
S100A8/A9 is increased in the serum and tissue of patients with iSGS. In this cohort of iSGS patients, serum S100A8/A9 was associated with surgery‐free intervals, potentially representing a prognostic biomarker. Further research within a larger cohort is needed to confirm these findings. Level of Evidence 3 Laryngoscope , 135:1724–1731, 2025
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A.
- Department of Otolaryngology Head and Neck Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee, U.S.A.
ORCID-Profile: Laura M Mafla, Raymond J So, Yee Chan-Li, Ioan A Lina, Alexander H Gelbard, Alexander T Hillel, Kevin M Motz
Förderung
- NIDCD NIH HHS
- NHLBI NIH HHS
- National Institute on Deafness and Other Communication Disorders
- National Heart, Lung, and Blood Institute
Zitieren
APA
Mafla, L. M., So, R. J., Abd-Elazem, I., Collins, S. L., Chan-Li, Y., Lilly, G., Lina, I. A., Gelbard, A. H., Hillel, A. T., & Motz, K. M. (2025). Serum S100A8 / A9 Correlates to Surgery‐Free Interval in Idiopathic Subglottic Stenosis. The Laryngoscope. https://doi.org/10.1002/lary.31934
Vancouver
Mafla LM, So RJ, Abd-Elazem I, Collins SL, Chan-Li Y, Lilly G, et al. Serum S100A8 / A9 Correlates to Surgery‐Free Interval in Idiopathic Subglottic Stenosis. The Laryngoscope. 2025. doi:10.1002/lary.31934
BibTeX
@article{Mafla2025,
author = {Mafla, Laura M and So, Raymond J and Abd-Elazem, Ibrahim and Collins, Samuel L and Chan-Li, Yee and Lilly, Gabriela and Lina, Ioan A and Gelbard, Alexander H and Hillel, Alexander T and Motz, Kevin M},
title = {Serum S100A8 / A9 Correlates to Surgery‐Free Interval in Idiopathic Subglottic Stenosis},
journal = {The Laryngoscope},
year = {2025},
doi = {10.1002/lary.31934}
}
EUVIMED